Standout Papers

CAL-101, a p110δ selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell ma... 2010 2026 2015 2020 583
  1. CAL-101, a p110δ selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viability (2010)
    Brian J. Lannutti, Sarah Meadows et al. Blood
  2. OncogenicCSF3RMutations in Chronic Neutrophilic Leukemia and Atypical CML (2013)
    Julia E. Maxson, Jason Gotlib et al. New England Journal of Medicine

Immediate Impact

2 by Nobel laureates 29 from Science/Nature 57 standout
Sub-graph 1 of 23

Citing Papers

CAR immune cells: design principles, resistance and the next generation
2023 StandoutNature
Copper induces cell death by targeting lipoylated TCA cycle proteins
2022 StandoutScience
3 intermediate papers

Works of Jeffrey Tyner being referenced

The TP53 Apoptotic Network Is a Primary Mediator of Resistance to BCL2 Inhibition in AML Cells
2019
Identification of Interleukin-1 by Functional Screening as a Key Mediator of Cellular Expansion and Disease Progression in Acute Myeloid Leukemia
2017
and 1 more

Author Peers

Author Last Decade Papers Cites
Jeffrey Tyner 2842 3207 2093 232 6.9k
Martin Sattler 3082 4267 1529 150 8.5k
Justus Duyster 3447 3853 2148 255 8.8k
Norio Komatsu 2734 2526 1742 382 6.5k
Paresh Vyas 4947 4372 1774 229 9.2k
Bruno Quesnel 3565 3460 1884 199 7.9k
Didier Bouscary 2234 3414 1046 161 6.2k
David A. Rizzieri 4236 2990 1554 305 7.9k
Gail J. Roboz 4812 3498 1996 313 7.4k
Anna Porwit 4269 2129 2540 173 7.1k
Jerry A. Katzmann 5249 4974 2507 171 10.3k

All Works

Loading papers...

Rankless by CCL
2026